GSK (GSK) reported better-than-expected financials for Q1 2026 on Wednesday as sales from its HIV and cancer medicines offset a sales decline for its general medicines, including its respiratory ...

GSK has finally called time on its pact with Mersana Therapeutics despite sinking $100 million to secure an option for an antibody-drug conjugate (ADC). That deal, signed back in 2022, centered on XMT ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Nico O'Reilly played an integral role in Manchester City's crucial win against Arsenal on Sunday Carl Recine/Getty Images Three seasons ago, having experienced varying levels of success in trying to ...

GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief Executive Officer Luke Miels tries to revitalize a company not known for its risk ...

GSK’s planned investment of up to $800 million in its campus near Marietta got a $9 million boost from a state Redevelopment Capital Assistance Program grant earlier this year. The grant is part of ...

GSK (GSK) announced on Thursday that the U.S. FDA approved Lynavoy as a treatment for an itching condition called cholestatic pruritus associated with primary biliary cholangitis (PBC), a rare ...

GSK struck a $950 million deal to buy Canada’s 35Pharma, a biopharmaceutical company developing cardiopulmonary treatments, as the U.K. drugmaker seeks to bolster its exposure to diseases linked to ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. LONDON — Building up its base of ...

Drugmaker GSK said it agreed to acquire Californian biopharmaceutical company RAPT Therapeutics for around $2.2 billion, a move set to bolster its respiratory, immunology and inflammation portfolio.

Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...

GSK Plc said it won US approval for a drug to treat severe asthma, boosting its prospects as a potential blockbuster. The US Food and Drug Administration approved Exdensur as an add-on maintenance ...